期刊文献+

微生物来源的免疫抑制剂 被引量:8

下载PDF
导出
摘要 环孢素的出现带来了器官移植革命性的变化,同时也促进了微生物来源的其它新型高效免疫抑制剂研究和发展。对微生物来源的几种重要的免疫抑制剂(麦考酚酸酯、麦考酚酸钠、他克莫司、西罗莫司和15-DSG)的来源、作用机制、相关性、不良反应等方面作了介绍。
出处 《国外医药(抗生素分册)》 CAS 2005年第5期233-237,共5页 World Notes on Antibiotics
  • 相关文献

参考文献29

  • 1Lazary S, Stahelin H. Immunosuppressive and specific antimitotic effects of ovalicin [J].Experientia,1968,24:1171.
  • 2程元荣.生物药物素及其寻找[J].中国抗生素杂志,1993,18(2):90-105. 被引量:4
  • 3夏穗生.中国器官移植现状[J].中华器官移植杂志,1995,16:90-90.
  • 4Khachatryan N, Wauters JP, Vogel G. Effect of mycophenolate mofetil in combination with standard immunosuppression on chronic transplant nephropathy:1 year experience[J]. Transplant Proc ,2002,34: 807.
  • 5The mycophenolate mofetil renal refractory rejection study group. Mycophenolate mofetil for the treatment of refractory,acute, cellular renal transplant rejection [ J ]. Transplantation,1996,61 (5) :722.
  • 6Engl T, Makarevic J, Relja B, et al. Mycophenolate mofetil modulates adhesion receptors of the betal integrin family on tumorcells: impact on tumor recurrence and malignancy[J].BMC Cancer,2005,5 (1):4.
  • 7Zanker B, Schneeberger H, Rothenpieler U, et al. Mycophenolate mofetil-based,cyclosporin-free induction and maintenance immunosuppression [ J ]. Transplantation, 1998, 66(1):44.
  • 8Gonzalez Molina M, Seron D, Garcia del Moral R, et al.Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplontation: a Spanish multicenter study[ J]. Transplant Proc,2002,34( 1 ) :335.
  • 9Rihs G, Papageorgiou C, Pfeifer S. Sodium mycophenolate[J].Acta Crystallogr C,2000,56( Pt 4) :432.
  • 10Haeberlin B. Enteric-coated pharmaceutical compositions of mycophenolate [ P]. US 6025391,2000-02-15.

二级参考文献54

  • 1Hughes SE, Gruber SA. New immunosuppressqve drugs in organ transplantation. J Clin Pharmacol, 1996, 36:1081-1092.
  • 2Hachida M, Zhang XL, Hualu, et al. Effects of immunosuppressants on platlet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis and coronary arteriosclerosis in rat cardiac allograft. Jpn Circ J, 1999, 63:303-308.
  • 3Zhao XM, Yeoh TK, Frist WH, et al. Induction of acidic fibroblast growth factor and full-length platlet-derived growth factor expression in human cardiac allografts. Circulation, 1994, 90:677-685.
  • 4Shaddy RE, Hammond EH, Yowell RL. Immunohistochemical analysis of platlet-derived growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol, 1996,77:1210-1215.
  • 5Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg, 1969, 57:225-229.
  • 6Oana S, Matsuoka R, Nakajima H, et al. Molecular characterization of a novel atrial-specific myosin heavy-chain gene expression in the chick embryo. Eur J Cell Biol, 1995, 61:42-49.
  • 7Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.Science, 1988, 239:487-491.
  • 8Libby P, Tanaka H. The pathogenesis of coronary aeteriosclerosis(chronic rejection) in transplanted hearts. Clin Transplant, 1994,8:313-318.
  • 9Kronke M, Leonard WJ, Depper JM, et al. Cydosporine inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA, 1984, 80:5214-5218.
  • 10Sudhir K, MacGregor JS, DeMarco T. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance arteries. Circulation, 1991, 90:3018-3023.

共引文献37

同被引文献208

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部